84 related articles for article (PubMed ID: 19117363)
21. Follow-up study of variants of the GIGYF2 gene in Chinese patients with Parkinson’s disease.
Wang L; Guo JF; Zhang WW; Xu Q; Zuo X; Shi CH; Luo LZ; Liu J; Hu L; Hu YC; Yan XX; Tang BS
J Clin Neurosci; 2011 Dec; 18(12):1699-701. PubMed ID: 22115759
[TBL] [Abstract][Full Text] [Related]
22. A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease.
Sutherland G; Mellick G; Sue C; Chan DK; Rowe D; Silburn P; Halliday G
Neurosci Lett; 2007 Mar; 414(2):170-3. PubMed ID: 17280783
[TBL] [Abstract][Full Text] [Related]
23. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
[TBL] [Abstract][Full Text] [Related]
24. Update on the genetics of Parkinson's disease.
Gasser T
Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395
[TBL] [Abstract][Full Text] [Related]
25. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
[TBL] [Abstract][Full Text] [Related]
26. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
27. Distribution, type, and origin of Parkin mutations: review and case studies.
Hedrich K; Eskelson C; Wilmot B; Marder K; Harris J; Garrels J; Meija-Santana H; Vieregge P; Jacobs H; Bressman SB; Lang AE; Kann M; Abbruzzese G; Martinelli P; Schwinger E; Ozelius LJ; Pramstaller PP; Klein C; Kramer P
Mov Disord; 2004 Oct; 19(10):1146-57. PubMed ID: 15390068
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease.
Bardien S; Keyser R; Yako Y; Lombard D; Carr J
Parkinsonism Relat Disord; 2009 Feb; 15(2):116-21. PubMed ID: 18514563
[TBL] [Abstract][Full Text] [Related]
29. PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease.
Zimprich A; Schulte C; Reinthaler E; Haubenberger D; Balzar J; Lichtner P; El Tawil S; Edris S; Foki T; Pirker W; Katzenschlager R; Daniel G; Brücke T; Auff E; Gasser T
Parkinsonism Relat Disord; 2009 Aug; 15(7):532-4. PubMed ID: 19250854
[TBL] [Abstract][Full Text] [Related]
30. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
Oliveira SA; Scott WK; Martin ER; Nance MA; Watts RL; Hubble JP; Koller WC; Pahwa R; Stern MB; Hiner BC; Ondo WG; Allen FH; Scott BL; Goetz CG; Small GW; Mastaglia F; Stajich JM; Zhang F; Booze MW; Winn MP; Middleton LT; Haines JL; Pericak-Vance MA; Vance JM
Ann Neurol; 2003 May; 53(5):624-9. PubMed ID: 12730996
[TBL] [Abstract][Full Text] [Related]
31. Parkin variants in North American Parkinson's disease: cases and controls.
Lincoln SJ; Maraganore DM; Lesnick TG; Bounds R; de Andrade M; Bower JH; Hardy JA; Farrer MJ
Mov Disord; 2003 Nov; 18(11):1306-11. PubMed ID: 14639672
[TBL] [Abstract][Full Text] [Related]
32. Reported mutations in GIGYF2 are not a common cause of Parkinson's disease.
Vilariño-Güell C; Ross OA; Soto AI; Farrer MJ; Haugarvoll K; Aasly JO; Uitti RJ; Wszolek ZK
Mov Disord; 2009 Mar; 24(4):619-20. PubMed ID: 19133664
[No Abstract] [Full Text] [Related]
33. Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease.
Maraganore DM; Farrer MJ; Lesnick TG; de Andrade M; Bower JH; Hernandez D; Hardy JA; Rocca WA
Mov Disord; 2003 Nov; 18(11):1233-9. PubMed ID: 14639662
[TBL] [Abstract][Full Text] [Related]
34. GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment.
Ruiz-Martinez J; Krebs CE; Makarov V; Gorostidi A; Martí-Massó JF; Paisán-Ruiz C
J Hum Genet; 2015 Oct; 60(10):637-40. PubMed ID: 26134514
[TBL] [Abstract][Full Text] [Related]
35. Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.
Quattrone A; Bagnato A; Annesi G; Novellino F; Morgante L; Savettieri G; Zappia M; Tarantino P; Candiano IC; Annesi F; Civitelli D; Rocca FE; D'Amelio M; Nicoletti G; Morelli M; Petrone A; Loizzo P; Condino F
Mov Disord; 2008 Jan; 23(1):21-7. PubMed ID: 17975812
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
Gao L; Gómez-Garre P; Díaz-Corrales FJ; Carrillo F; Carballo M; Palomino A; Díaz-Martín J; Mejías R; Vime PJ; López-Barneo J; Mir P
Eur J Neurol; 2009 Aug; 16(8):957-60. PubMed ID: 19473361
[TBL] [Abstract][Full Text] [Related]
37. The contribution of GIGYF2 to Parkinson's disease: a meta-analysis.
Zhang Y; Sun QY; Yu RH; Guo JF; Tang BS; Yan XX
Neurol Sci; 2015 Nov; 36(11):2073-9. PubMed ID: 26152800
[TBL] [Abstract][Full Text] [Related]
38. Lack of replication of association between GIGYF2 variants and Parkinson disease.
Bras J; Simón-Sánchez J; Federoff M; Morgadinho A; Januario C; Ribeiro M; Cunha L; Oliveira C; Singleton AB
Hum Mol Genet; 2009 Jan; 18(2):341-6. PubMed ID: 18923002
[TBL] [Abstract][Full Text] [Related]
39. EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts.
Huttenlocher J; Krüger R; Capetian P; Lohmann K; Brockmann K; Csoti I; Klein C; Berg D; Gasser T; Bonin M; Riess O; Bauer P
J Med Genet; 2015 Jan; 52(1):37-41. PubMed ID: 25368108
[TBL] [Abstract][Full Text] [Related]
40. The GIGYF2 variants are not associated with Parkinson's disease in the mainland Chinese population.
Cao L; Zhang T; Zheng L; Wang Y; Wang G; Zhang J; Fei QZ; Cui PJ; Wang XJ; Ma JF; Xiao Q; Chen SD
Parkinsonism Relat Disord; 2010 May; 16(4):294-7. PubMed ID: 20044296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
